Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPACT-P9 Study
jRCT1031250266Recruiting
- Sponsor
- No
- Start
- Jul 2025
- Countries
- 1
01
Overview
Open-label trial in acute coronary syndrome (ACS) (2 arms), sponsored by No. Primary endpoint: Change in culprit-vessel plaque volume on IVUS at 6 months. Started Jul 2025; status: recruiting.
02
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on jRCT1031250266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031250266.